Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-40
SponsorART Fertility Clinics LLC

About this trial

To describe the peripheral serum levels of the anti-inflammatory cytokines IL-4 (Interleukin-4), IL-10 (Interleukin-10), TGF-ß1 (Transforming Growth Factor beta1), the pro-inflammatory cytokines IL-17 (Interleukin-17), IFγ (Interferon Gamma) and the immune mediator PIBF (Progesterone-Induced Blocking Factor) along a single frozen euploid blastocyst transfer in a natural cycle (NC) or Hormone Replacement Therapy (HRT).

Eligibility criteria

Qualifiers

Women aged 18 years to 40 years

Having at least one good quality (grade A or B for inner mass cell and trophectoderm) day 5 or 6 chromosomally normal cryopreserved blastocyst available for transfer

Single embryo transfer in a natural cycle (NC) or an Hormone Replacement Therapy (HRT) protocol

Fresh ejaculate used for fertilization

Disqualifiers

Body mass index lower than 18.5 or equal or higher than 29 kg/m2

Endometriosis or adenomyosis suspected by medical history (dysmenorrhea, dyspareunia, heavy or prolonged menstrual bleeding (> 8 days), chronic pelvic pain, catamenial rectal or bladder symptoms) or diagnosed by imaging (magnetic resonance imaging or ultrasonography)

Uterine abnormalities

Hydrosalpinx

Trial design

Treatments tested in this trial

  • Endometrin 100Mg Vaginal Insert
  • Estradiol Valerate

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators